Helus Pharma (Nasdaq: HELP, Cboe CA: HELP) announced it has completed enrollment in the APPROACH Phase 3 pivotal study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE